Curative Biosciences, Inc. (CBDX)

[stlogic]

Net Loss
Net loss for the year ended June 30, 2013 was $6,637,805 (including settlement expenses of $5,799,500) as compared to $7,998,164 (included settlement expenses of $1,719,000) for the same period in 2012. The decrease was due primarily to the issuance of stock for independent contractor and wage expenses in the year ended June 30, 2012

Revs were peanuts


The business Bill and Kathy know how to run is the Shell Game

That's not my opinion but a proven fact